Wealth Advisory Solutions’s Epizyme, Inc EPZM Stock Holding History

Wealth Advisory Solutions’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$15K	–	165
2022 Q2	$15K	Hold	10,000	–	–	﹤0.01%	145
2022 Q1	$12K	Buy	+10,000	New	+$16.3K	﹤0.01%	147

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Wealth Advisory Solutions's EPZM Position: Q3 2022 in Review

Wealth Advisory Solutions sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 10,000 shares — an estimated $15K sold.

Wealth Advisory Solutions first reported a position in EPZM in Q1 2022 and held it in 2 quarters. The position peaked at $15K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Wealth Advisory Solutions reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Wealth Advisory Solutions sold 10,000 Epizyme, Inc shares in Q3 2022, an estimated $15K.
Wealth Advisory Solutions first reported a position in Epizyme, Inc in Q1 2022 and held it in 2 quarters.
Wealth Advisory Solutions's Epizyme, Inc position peaked at $15K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Wealth Advisory Solutions's 13F filing for Q3 2022, filed 16 Nov 2022.